Quest Diagnostics partners with Google Cloud for data management and AI personalization

Investing.com -- Quest Diagnostics (NYSE: NYSE:DGX), a prominent player in diagnostic information services, announced today a partnership with Google (NASDAQ:GOOGL) Cloud. This collaboration aims to enhance Quest’s data management, refine data analytics, and provide personalized experiences to patients, providers, and other customers.

The partnership will see Quest Diagnostics utilize Google Cloud’s data analytics and generative AI (gen AI) technologies. These include Google Agentspace, a platform that employs gen AI to link employees and customers with enterprise-wide knowledge and automate intricate tasks using intelligent, customizable agents. This venture marks one of the first times a national laboratory provider has employed these technologies across various operations and administrative areas such as R&D, customer experience, and operations. All these while ensuring data privacy and security.

Murali Balakumar, senior vice president and chief information and digital officer at Quest Diagnostics, expressed enthusiasm about the potential to innovate and personalize their services. He praised Google Cloud for offering a top-notch platform for securely streamlining and integrating data to produce unique insights and boost productivity. Google Cloud’s gen AI can aid in eliminating care obstacles by personalizing patient and provider interactions, thus enhancing care access, customer experiences, and quality.

The collaboration will focus on refining Quest’s systems to elevate data quality, management, and security. The partners will also investigate the application of gen AI in numerous areas. These include enhancing patient engagement by allowing patients and consumers to derive personalized health insights from their lab data, and empowering physicians with lab insights and other data to improve individual patient care.

Mark S. Clare, vice president and chief data officer at Quest Diagnostics, said that working with Google will enable them to develop new capabilities for serving patients, healthcare providers, and other customers. He noted that data management has undergone significant changes recently and is accelerating with gen AI. The partnership with Google will allow Quest to leverage the rapidly evolving technology landscape to enhance customer insights responsibly, securely, and reliably.

Thomas Kurian, CEO of Google Cloud, said the partnership with Quest Diagnostics represents a significant moment in healthcare innovation. By integrating Google Cloud’s advanced AI and data analytics capabilities with Quest’s extensive network and deep healthcare expertise, they aim to improve diagnostics and patient care. They envision a future where healthcare is more personalized, proactive, and accessible for everyone.

Quest anticipates that the relationship with Google will bolster its hybrid cloud strategy by expanding data and AI capabilities and enhancing productivity. In 2024, Quest processed over 200 million test requisitions and managed more than 80 billion data points. Google Cloud’s HIPAA-compliant infrastructure and secure data storage, along with Quest’s security and privacy controls and processes, will ensure the protection of patient data access and usage.

The partnership with Google aligns with Quest’s strategy to implement AI and automation technologies to improve productivity, service, quality, and innovation. The company has successfully deployed AI and automation in several areas of its organization, including microbiology and cytology testing, specimen processing, and customer service.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.